Showing 14,281 - 14,300 results of 99,080 for search '(( 50 ((ns decrease) OR (nn decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 14281
  2. 14282

    Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
  3. 14283

    CONSORT flow diagram. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
  4. 14284

    Adverse events in placebo arm. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
  5. 14285

    Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
  6. 14286
  7. 14287

    Dot1a represses Aqp5 mRNA expression in mouse cortical collecting duct M1 and mouse lung epithelial MLE-15 cells. by Hongyu Wu (104579)

    Published 2013
    “…<p>(<b>A–B</b>) Real-time RT-qPCR showing that siRNA-mediated depletion of Dot1la in M1 cells increases endogenous Aqp5 expression (<b>A</b>) and that overexpression of Dot1a decreases endogenous Aqp5 expression in MLE-15 cells (<b>B</b>). …”
  8. 14288
  9. 14289
  10. 14290
  11. 14291
  12. 14292
  13. 14293
  14. 14294
  15. 14295

    BMD analysis of red cell count (A), hematocrit (B) and hemoglobin (C) in males (triangles) and females (circles). by Matti Viluksela (321291)

    Published 2014
    “…<p>These parameters were dose-dependently decreased in both genders. Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease (CES -0.05) compared to background (a parameter). …”
  16. 14296

    eGFR trajectories by type of physical activity. by Ronit Calderon-Margalit (584756)

    Published 2025
    “…</p><p>Results</p><p>During 9.5 years of follow-up, the eGFR decreased by 0.97 ml/min/1.73m<sup>2</sup> per year. …”
  17. 14297
  18. 14298
  19. 14299
  20. 14300